Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results.

Pitteri M, Dapor C, Pisani AI, Castellaro M, DeLuca J, Chiaravalloti N, Guandalini M, Ziccardi S, Calabrese M.

J Neuropsychol. 2019 Nov 30. doi: 10.1111/jnp.12198. [Epub ahead of print]

PMID:
31785082
2.

Lost in Classification: Lower Cognitive Functioning in Apparently Cognitive Normal Newly Diagnosed RRMS Patients.

Pitteri M, Ziccardi S, Dapor C, Guandalini M, Calabrese M.

Brain Sci. 2019 Nov 13;9(11). pii: E321. doi: 10.3390/brainsci9110321.

3.

Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.

Ferraro D, Annovazzi P, Moccia M, Lanzillo R, De Luca G, Nociti V, Fantozzi R, Paolicelli D, Ragonese P, Gajofatto A, Boffa L, Cavalla P, Lo Fermo S, Buscarinu MC, Lorefice L, Cordioli C, Calabrese M, Gallo A, Pinardi F, Tortorella C, Di Filippo M, Camera V, Maniscalco GT, Radaelli M, Buttari F, Tomassini V, Cocco E, Gasperini C, Solaro C; RIREMS (Rising Researchers in Multiple Sclerosis).

Mult Scler Relat Disord. 2019 Oct 19;37:101461. doi: 10.1016/j.msard.2019.101461. [Epub ahead of print]

PMID:
31678859
4.

Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.

Magliozzi R, Hametner S, Facchiano F, Marastoni D, Rossi S, Castellaro M, Poli A, Lattanzi F, Visconti A, Nicholas R, Reynolds R, Monaco S, Lassmann H, Calabrese M.

Ann Clin Transl Neurol. 2019 Nov;6(11):2150-2163. doi: 10.1002/acn3.50893. Epub 2019 Nov 1.

5.

Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.

Magliozzi R, Marastoni D, Rossi S, Castellaro M, Mazziotti V, Pitteri M, Gajofatto A, Monaco S, Benedetti MD, Calabrese M.

BMC Neurol. 2019 Sep 26;19(1):231. doi: 10.1186/s12883-019-1455-7.

6.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
7.

Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.

Marastoni D, Buriani A, Pisani AI, Crescenzo F, Zuco C, Fortinguerra S, Sorrenti V, Marenda B, Romualdi C, Magliozzi R, Monaco S, Calabrese M.

Front Immunol. 2019 Jul 19;10:1666. doi: 10.3389/fimmu.2019.01666. eCollection 2019.

8.

Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis.

Gajofatto A, Donisi V, Busch IM, Gobbin F, Butturini E, Calabrese M, Carcereri de Prati A, Cesari P, Del Piccolo L, Donadelli M, Fabene P, Fochi S, Gomez-Lira M, Magliozzi R, Malerba G, Mariotti R, Mariotto S, Milanese C, Romanelli MG, Sbarbati A, Schena F, Mazzi MA, Rimondini M.

BMJ Open. 2019 Aug 2;9(8):e030469. doi: 10.1136/bmjopen-2019-030469.

9.

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Calabrese M, Gasperini C, Tortorella C, Schiavi G, Frisullo G, Ragonese P, Fantozzi R, Prosperini L, Annovazzi P, Cordioli C, Di Filippo M, Ferraro D, Gajofatto A, Malucchi S, Lo Fermo S, De Luca G, Stromillo ML, Cocco E, Gallo A, Paolicelli D, Lanzillo R, Tomassini V, Pesci I, Rodegher ME, Solaro C; RIREMS group (Rising Italian Researchers in Multiple Sclerosis).

Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.

10.

Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment.

Pitteri M, Genova H, Lengenfelder J, DeLuca J, Ziccardi S, Rossi V, Calabrese M.

Mult Scler Relat Disord. 2019 Apr;29:118-123. doi: 10.1016/j.msard.2019.01.030. Epub 2019 Jan 23.

PMID:
30710839
11.

Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis.

Crescenzo F, Marastoni D, Zuco C, Pitteri M, Magliozzi R, Monaco S, Calabrese M.

Mult Scler Relat Disord. 2019 Jan;27:305-311. doi: 10.1016/j.msard.2018.11.009. Epub 2018 Nov 12.

PMID:
30453199
12.

MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course.

Magliozzi R, Reynolds R, Calabrese M.

Brain Pathol. 2018 Sep;28(5):735-742. doi: 10.1111/bpa.12642.

PMID:
30020563
13.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

14.

The effect of fingolimod on focal and diffuse grey matter damage in active MS patients.

Bajrami A, Pitteri M, Castellaro M, Pizzini F, Romualdi C, Montemezzi S, Monaco S, Calabrese M.

J Neurol. 2018 Sep;265(9):2154-2161. doi: 10.1007/s00415-018-8952-2. Epub 2018 Jun 25.

PMID:
29938336
15.

Multiple sclerosis and epilepsy: much more than a coincidence.

Calabrese M.

Eur J Neurol. 2018 Sep;25(9):1103-1104. doi: 10.1111/ene.13727. Epub 2018 Jul 10. No abstract available.

PMID:
29931718
16.

The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis.

Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, Monaco S, Muraro PA, Calabrese M.

Neurology. 2018 Jun 12;90(24):e2107-e2118. doi: 10.1212/WNL.0000000000005685. Epub 2018 May 16.

17.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, Di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C; R.I.Re.MS study group.

J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

PMID:
29549468
18.

Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.

Magliozzi R, Howell OW, Nicholas R, Cruciani C, Castellaro M, Romualdi C, Rossi S, Pitteri M, Benedetti MD, Gajofatto A, Pizzini FB, Montemezzi S, Rasia S, Capra R, Bertoldo A, Facchiano F, Monaco S, Reynolds R, Calabrese M.

Ann Neurol. 2018 Apr;83(4):739-755. doi: 10.1002/ana.25197.

19.

Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables.

Pitteri M, Magliozzi R, Bajrami A, Camera V, Calabrese M.

Expert Opin Pharmacother. 2018 Mar;19(4):387-395. doi: 10.1080/14656566.2018.1434143. Epub 2018 Feb 3. Review.

PMID:
29397790
20.

Physical rehabilitation modulates microRNAs involved in multiple sclerosis: a case report.

Vallelunga A, Berlingieri C, Ragusa M, Purrello M, Stabile MR, Calabrese MC, Morales-Medina JC, Palmieri B, Iannitti T.

Clin Case Rep. 2017 Nov 2;5(12):2040-2043. doi: 10.1002/ccr3.1100. eCollection 2017 Dec.

Supplemental Content

Loading ...
Support Center